Release 5 R6 Ballot (1st Draft)

This page is part of the FHIR Specification (v5.0.0: R5 - STU v6.0.0-ballot1: Release 6 Ballot (1st Draft) (see Ballot Notes ). This is the The current published version in it's permanent home (it will always be available at this URL). is 5.0.0 . For a full list of available versions, see the Directory of published versions . Page versions: R5 R4B R4 R3 R2

Example DetectedIssue/ddi (XML)

Clinical Decision Support Work Group Maturity Level : N/A Standards Status : Informative Compartments : Device , Patient , Practitioner

Raw XML ( canonical form + also see XML Format Specification )

Jump past Narrative

Drug-drug interaction between prescription and medication statement (id = "ddi")

<?xml version="1.0" encoding="UTF-8"?>

  
  
    
    
      

<DetectedIssue xmlns="http://hl7.org/fhir">
  <id value="ddi"/> 
  <text> 
    <status value="generated"/> 
    <div xmlns="http://www.w3.org/1999/xhtml">
      <p> <b> Severity: High</b>  - Risk of internal bleeding</p> 
      <p> Those who take acetaminophen along with the widely used blood-thinning drug warfarin
         may face the risk of serious internal bleeding. People on warfarin who take acetaminophen
         for at least seven days in a row should be closely watched for bleeding.
      
        
        
      
      

         for at least seven days in a row should be closely watched for bleeding.</p> 
      <ul> 
        <li> <a href="MedicationStatement/tylenol">500 mg Acetaminophen tablet 1/day, PRN since 2010</a> </li> 
        <li> <a href="MedicationRequest/warfarin">Warfarin 1 MG TAB prescribed Jan. 5, 2014</a> </li> 
      </ul> 
      <p> Mitigation: Jan 5, 2014 by Dr. Adam Careful: </p> 
      <p> Asked patient to discontinue regular use of Tylenol and to consult with clinician
         if they need to resume to allow appropriate INR monitoring
    
  
  
  
    
      
      
      
    
  
  
    
      
      
      
    
  
  
  
    
  
  
  
    
    
  
  
    
    
  

         if they need to resume to allow appropriate INR monitoring</p> 
    </div> 
  </text> 
  <status value="final"/> 
  <category> 
    <coding> 
      <system value="http://terminology.hl7.org/CodeSystem/v3-ActCode"/> 
      <code value="DRG"/> 
      <display value="Drug Interaction Alert"/> 
    </coding> 
  </category> 
  <code> 
    <coding> 
      <system value="http://terminology.hl7.org/CodeSystem/v3-ActCode"/> 
      <code value="DRG"/> 
      <display value="Drug Interaction Alert"/> 
    </coding> 
  </code> 
  <severity value="high"/> 
  <subject> 
    <reference value="Device/example"/> 
  </subject> 
  <identifiedDateTime value="2014-01-05"/> 
  <implicated> 
    <reference value="MedicationStatement/example001"/> 
    <display value="500 mg Acetaminophen tablet 1/day, PRN since 2010"/> 
  </implicated> 
  <implicated> 
    <reference value="MedicationRequest/medrx0331"/> 
    <display value="Warfarin 1 MG TAB prescribed Jan. 15, 2015"/> 
  </implicated> 
  <detail value="Risk of internal bleeding.  Those who take acetaminophen along with the widely
   used blood-thinning drug warfarin may face the risk of serious internal bleeding.
   People on warfarin who take acetaminophen for at least seven days in a row should
   be closely watched for bleeding.
  
    
      
        
        
        
      

   be closely watched for bleeding."/> 
  <mitigation> 
    <action> 
      <coding> 
        <system value="http://terminology.hl7.org/CodeSystem/v3-ActCode"/> 
        <code value="13"/> 
        <display value="Stopped Concurrent Therapy"/> 
      </coding> 
      <text value="Asked patient to discontinue regular use of Tylenol and to consult with clinician
       if they need to resume to allow appropriate INR monitoring
    
    
    
      
      
    
  

       if they need to resume to allow appropriate INR monitoring"/> 
    </action> 
    <date value="2014-01-05"/> 
    <author> 
      <reference value="Practitioner/example"/> 
      <display value="Dr. Adam Careful"/> 
    </author> 
  </mitigation> 


</

DetectedIssue

>



Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.